Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy
Explore this paper's citation graph
Summary
Several clinical, laboratory, imaging, histopathologic, and genetic biomarkers that have been tested as tools to predict which patients are most likely to have a pathologic complete response (pCR) after nCRT are explored.
- Type
- article
- Published
- 2013-08-14
- Cited by
- 8
- References
- 126
- Access
- Open access
- OpenAlex
- https://openalex.org/W23983475
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:4995086
Keywords
Computer science
References
- Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
- Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
- Microarray Gene Expression Profiling for Predicting Complete Response to Preoperative Chemoradiotherapy in Patients with Advanced Rectal Cancer
- Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?
- Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma
- Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation
- A single‐centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management?
- Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.
- Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?
- Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy
- Nonoperative approaches to rectal cancer: a critical evaluation.
- Comparison between CT volume measurement and histopathological assessment of response to neoadjuvant therapy in rectal cancer.
- Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique
- Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
- Total mesorectal excision: Assessment of the laparoscopic approach
- Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy
- XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer.
- Combined Modality Therapy for Rectal Cancer: The Relative Value of Posttreatment Versus Pretreatment CEA as a Prognostic Marker for Disease Recurrence
- A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.
- The Potential of Restaging in the Prediction of Pathologic Response After Preoperative Chemoradiotherapy for Rectal Cancer
Cited by
- High nodal positivity rates even in good clinical responders after chemoradiation of rectal cancer: is organ preservation feasible?
- Multidisciplinary treatment of rectal cancer in 2014: where are we going?
- MR guidance in radiotherapy
- Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or “watch and wait”
- Is surgery always necessary in rectal cancer?
- Personalized Treatment in Rectal Cancer – a Single Center Study
- A DJUVANT THERAPY FOR COLORECTAL CANCER
- MR guidance in radiotherapy
Related papers
No related papers recorded.